Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Cell Chemical Biology|August 2, 2023
Small molecule targeting of transcription-replication conflict for selective chemotherapyLong Gu, Min Li, Caroline M Li, et al.
JAMIA Open|February 7, 2020
A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patientsMichael J Pishvaian, Edik M Blais, R Joseph Bender, et al.
Scientific Reports|April 29, 2020
Indoor incense burning impacts cognitive functions and brain functional connectivity in community older adultsAdrian Wong, Wutao Lou, Kin-Fai Ho, et al.
British Journal of Clinical Pharmacology|July 5, 2019
A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunctionNaoko Takebe, Jan H Beumer, Shivaani Kummar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2013
Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group studyStephen I Shibata, Vincent Chung, Timothy W Synold, et al.
Aging|June 6, 2021
MRI-based Alzheimer's disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer's diseaseWanting Liu, Lisa Wing Chi Au, Jill Abrigo, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancerSebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
Aerobic exercise in older people with subclinical sporadic cerebral small vessel disease: A randomized clinical trialAdrian Wong, Bonnie Yin Ka Lam, Margaret Kit Yi Mak, et al.
Investigational New Drugs|February 12, 2013
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignanciesGlen J Weiss, Joseph Chao, Jeffrey D Neidhart, et al.
Cancers|July 2, 2021
Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer PatientsMoom R Roosan, Isa Mambetsariev, Rebecca Pharaon, et al.
Pageof 16